719 related articles for article (PubMed ID: 8553028)
21. Experimental nephrolithiasis in rats: the effect of ethylene glycol and vitamin D3 on the induction of renal calcium oxalate crystals.
de Water R; Boevé ER; van Miert PP; Deng G; Cao LC; Stijnen T; de Bruijn WC; Schröder FH
Scanning Microsc; 1996; 10(2):591-601; discussion 601-3. PubMed ID: 9813634
[TBL] [Abstract][Full Text] [Related]
22. Strain differences in urinary factors that promote calcium oxalate crystal formation in the kidneys of ethylene glycol-treated rats.
Li Y; McMartin KE
Am J Physiol Renal Physiol; 2009 May; 296(5):F1080-7. PubMed ID: 19244400
[TBL] [Abstract][Full Text] [Related]
23. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
Khan SR
Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
[TBL] [Abstract][Full Text] [Related]
24. [Influence of urinary citrate levels on spontaneous calcium oxalate dihydrate crystalluria].
Hassani MA; Hennequin C; Lacour B; Daudon M
Prog Urol; 2005 Sep; 15(4):650-5. PubMed ID: 16459680
[TBL] [Abstract][Full Text] [Related]
25. Importance of mild hyperoxaluria in the pathogenesis of urolithiasis--new evidence from studies in the Arabian peninsula.
Robertson WG; Hughes H
Scanning Microsc; 1993 Mar; 7(1):391-401; discussion 401-2. PubMed ID: 8316808
[TBL] [Abstract][Full Text] [Related]
26. Modeling of hyperoxaluric calcium oxalate nephrolithiasis: experimental induction of hyperoxaluria by hydroxy-L-proline.
Khan SR; Glenton PA; Byer KJ
Kidney Int; 2006 Sep; 70(5):914-23. PubMed ID: 16850024
[TBL] [Abstract][Full Text] [Related]
27. Pathological and immunocytochemical changes in chronic calcium oxalate nephrolithiasis in the rat.
de Water R; Boevé ER; van Miert PP; Vermaire CP; van Run PR; Cao LC; de Bruijn WC; Schröder FH
Scanning Microsc; 1996; 10(2):577-87; discussion 587-90. PubMed ID: 9813633
[TBL] [Abstract][Full Text] [Related]
28. Characterization of Tamm-Horsfall protein in a rat nephrolithiasis model.
Gokhale JA; Glenton PA; Khan SR
J Urol; 2001 Oct; 166(4):1492-7. PubMed ID: 11547119
[TBL] [Abstract][Full Text] [Related]
29. Decreased renal expression of the putative calcium oxalate inhibitor Tamm-Horsfall protein in the ethylene glycol rat model of calcium oxalate urolithiasis.
Marengo SR; Chen DH; Kaung HL; Resnick MI; Yang L
J Urol; 2002 May; 167(5):2192-7. PubMed ID: 11956477
[TBL] [Abstract][Full Text] [Related]
30. Renal oxidative vulnerability due to changes in mitochondrial-glutathione and energy homeostasis in a rat model of calcium oxalate urolithiasis.
Meimaridou E; Lobos E; Hothersall JS
Am J Physiol Renal Physiol; 2006 Oct; 291(4):F731-40. PubMed ID: 16670437
[TBL] [Abstract][Full Text] [Related]
31. Fibronectin as a potent inhibitor of calcium oxalate urolithiasis.
Tsujihata M; Miyake O; Yoshimura K; Kakimoto KI; Takahara S; Okuyama A
J Urol; 2000 Nov; 164(5):1718-23. PubMed ID: 11025758
[TBL] [Abstract][Full Text] [Related]
32. Mechanism of calcium oxalate renal stone formation and renal tubular cell injury.
Tsujihata M
Int J Urol; 2008 Feb; 15(2):115-20. PubMed ID: 18269444
[TBL] [Abstract][Full Text] [Related]
33. A porcine model of calcium oxalate kidney stone disease.
Mandel NS; Henderson JD; Hung LY; Wille DF; Wiessner JH
J Urol; 2004 Mar; 171(3):1301-3. PubMed ID: 14767337
[TBL] [Abstract][Full Text] [Related]
34. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastrointestinal tract-dwelling bacterium Oxalobacter formigenes: possible prevention by gut recolonization or enzyme replacement therapy.
Sidhu H; Schmidt ME; Cornelius JG; Thamilselvan S; Khan SR; Hesse A; Peck AB
J Am Soc Nephrol; 1999 Nov; 10 Suppl 14():S334-40. PubMed ID: 10541258
[TBL] [Abstract][Full Text] [Related]
35. Calcium oxalate urolithiasis in the rat: is it a model for human stone disease? A review of recent literature.
Khan SR; Hackett RL
Scan Electron Microsc; 1985; (Pt 2):759-74. PubMed ID: 3901237
[TBL] [Abstract][Full Text] [Related]
36. Kinetics of early time calcium oxalate nephrolithiasis.
Jordan WR; Finlayson B; Luxenberg M
Invest Urol; 1978 May; 15(6):465-8. PubMed ID: 649295
[TBL] [Abstract][Full Text] [Related]
37. The use of SEM in the study of oxalate induced experimental nephrolithiasis.
Khan SR; Hackett RL
Scan Electron Microsc; 1980; (3):379-86. PubMed ID: 7414280
[TBL] [Abstract][Full Text] [Related]
38. Enteric hyperoxaluria, nephrolithiasis, and oxalate nephropathy: potentially serious and unappreciated complications of Roux-en-Y gastric bypass.
Nelson WK; Houghton SG; Milliner DS; Lieske JC; Sarr MG
Surg Obes Relat Dis; 2005; 1(5):481-5. PubMed ID: 16925274
[TBL] [Abstract][Full Text] [Related]
39. [14C-oxalate autoradiographic studies on distribution of oxalate and calcium oxalate crystal fixation in rat kidney].
Ishii K; Sugimoto T; Kamikawa S; Kanazawa T; Nakatani T; Yamamoto K; Kishimoto T; Funae Y
Hinyokika Kiyo; 1998 Apr; 44(4):245-51. PubMed ID: 9617620
[TBL] [Abstract][Full Text] [Related]
40. Acute hyperoxaluria, renal injury and calcium oxalate urolithiasis.
Khan SR; Shevock PN; Hackett RL
J Urol; 1992 Jan; 147(1):226-30. PubMed ID: 1729537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
